Pharma GCCs contribute $10.5 billion to India’s economy, says OPPI-EY report

0
14
India's pharma GCCs emerge as global innovation hubs with a $10.5 billion economic contribution | Credit: Fortune India
India's pharma GCCs emerge as global innovation hubs with a $10.5 billion economic contribution | Credit: Fortune India

Global Capability Centres (GCCs) established by multinational pharmaceutical companies in India could contribute up to $10.5 billion in gross value added (GVA) to the country’s economy, according to a joint report by the Organisation of Pharmaceutical Producers of India (OPPI) and EY.

Released at OPPI’s Annual Summit in New Delhi, the report estimates that pharmaceutical GCCs employ approximately 1.2 lakh professionals across India. Meanwhile, the country’s overall GCC sector is estimated to have generated 10.4 million jobs and occupied 34.9 million sq. ft. of office space in 2025. The sector also supports wider economic activity through its impact on suppliers, infrastructure and household consumption.

The report highlights that India hosts more than half of the world’s pharmaceutical GCC base. It also points to the evolution of the GCC model through 4 stages: from delivery and cost centres to capability centres, innovation partners and, eventually, enterprise-critical nodes.

Leading pharmaceutical GCCs are increasingly combining specialised industry knowledge with data, technology and enterprise expertise. Their performance is also being assessed through defined business and functional outcomes rather than simply the volume of activities delivered.

The report identifies several opportunities for the next phase of growth. These include expanding India’s ownership of end-to-end global capabilities, strengthening decision-making authority and accountability, and advancing science-to-patient innovation by combining scientific research with digital technologies and AI-powered discovery.

It also highlights the need for stronger partnerships with hospitals, clinical investigators and research infrastructure to position India as a leading global clinical research hub.

Another opportunity is to build an India-to-world ecosystem gateway, connecting global biopharma companies with India’s scientific, technological, clinical and innovation capabilities while helping Indian ideas reach global enterprise networks.

However, the report notes that achieving these ambitions will require coordinated efforts from GCCs, industry, government and academia. Key priorities include developing skilled talent, strengthening technology and scientific infrastructure, and creating a supportive operating environment.

It recommends developing India-based leaders for global roles, expanding decision-making authority within GCCs and strengthening industry readiness through practical exposure and continuous collaboration between industry and academia.

The report also calls for stronger computing and digital infrastructure to support AI-intensive operations, clearer science-led regulatory pathways, better intellectual property protection and trusted research-data governance.

For the government, the recommendations include simplifying compliance requirements, providing greater certainty around taxation and transfer pricing, and strengthening coordination between central and state authorities to improve India’s position as a global pharmaceutical GCC destination.

Also read: Viksit Workforce for a Viksit Bharat

Do Follow: The Mainstream LinkedIn | The Mainstream Facebook | The Mainstream Youtube | The Mainstream Twitter

About us:

The Mainstream is a premier platform delivering the latest updates and informed perspectives across the technology business and cyber landscape. Built on research-driven, thought leadership and original intellectual property, The Mainstream also curates summits & conferences that convene decision makers to explore how technology reshapes industries and leadership. With a growing presence in India and globally across the Middle East, Africa, ASEAN, the USA, the UK and Australia, The Mainstream carries a vision to bring the latest happenings and insights to 8.2 billion people and to place technology at the centre of conversation for leaders navigating the future.